-
1
-
-
85010664416
-
Reproducibility Project: Cancer Biology. 2017. Replication study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
-
Aird F, Kandela I, Mantis C, Reproducibility Project: Cancer Biology. 2017. Replication study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. eLife 6:e21253. doi: 10.7554/eLife.21253
-
Elife
, vol.6
-
-
Aird, F.1
Kandela, I.2
Mantis, C.3
-
2
-
-
84975246894
-
1,500 scientists lift the lid on reproducibility
-
Baker M. 2016. 1,500 scientists lift the lid on reproducibility. Nature 533:452-454. doi: 10.1038/533452a
-
(2016)
Nature
, vol.533
, pp. 452-454
-
-
Baker, M.1
-
3
-
-
84859169880
-
Drug development: Raise standards for preclinical cancer research
-
Begley CG, Ellis LM. 2012. Drug development: Raise standards for preclinical cancer research. Nature 483:531-533. doi: 10.1038/483531a
-
(2012)
Nature
, vol.483
, pp. 531-533
-
-
Begley, C.G.1
Ellis, L.M.2
-
4
-
-
85010653055
-
Mixed outcomes for computational predictions
-
Dang CV. 2017. Mixed outcomes for computational predictions. eLife 6:e22661. doi: 10.7554/eLife.22661
-
(2017)
Elife
, vol.6
-
-
Dang, C.V.1
-
5
-
-
85010665826
-
Melanoma mystery
-
Davis RJ. 2017. Melanoma mystery. eLife 6:e22662. doi: 10.7554/eLife.22662
-
(2017)
Elife
, vol.6
-
-
Davis, R.J.1
-
6
-
-
85005865052
-
An open investigation of the reproducibility of cancer biology research
-
Errington TM, Iorns E, Gunn W, Tan FE, Lomax J, Nosek BA. 2014. An open investigation of the reproducibility of cancer biology research. eLife 3: e04333. doi: 10.7554/eLife.04333
-
(2014)
Elife
, vol.3
-
-
Errington, T.M.1
Iorns, E.2
Gunn, W.3
Tan, F.E.4
Lomax, J.5
Nosek, B.A.6
-
7
-
-
85010695261
-
Making sense of replications
-
Errington TM, Nosek BA. 2017. Making sense of replications. eLife 6:e23383. doi: 10.7554/eLife.23383
-
(2017)
Elife
, vol.6
-
-
Errington, T.M.1
Nosek, B.A.2
-
8
-
-
85010664362
-
Reproducibility Project: Cancer Biology. 2017b. Replication study: Melanoma genome sequencing reveals frequent PREX2 mutations
-
Horrigan SK, Courville P, Sampey D, Zhou F, Cai S, Reproducibility Project: Cancer Biology. 2017b. Replication study: Melanoma genome sequencing reveals frequent PREX2 mutations. eLife 6:e21634. doi: 10.7554/eLife.21634
-
Elife
, vol.6
-
-
Horrigan, S.K.1
Courville, P.2
Sampey, D.3
Zhou, F.4
Cai, S.5
-
9
-
-
85010699903
-
Reproducibility Project: Cancer Biology. 2017a. Replication study: The CD47-signal regulatoryprotein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
-
Horrigan SK, Reproducibility Project: Cancer Biology. 2017a. Replication study: The CD47-signal regulatoryprotein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. eLife 6:e18173. doi: 10.7554/eLife.18173
-
Elife
, vol.6
-
-
Horrigan, S.K.1
-
10
-
-
85010699893
-
Reproducibility Project: Cancer Biology. 2017. Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data
-
Kandela I, Aird F, Reproducibility Project: Cancer Biology. 2017. Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data. eLife 6: e17044. doi: 10.7554/eLife.17044
-
Elife
, vol.6
-
-
Kandela, I.1
Aird, F.2
-
11
-
-
85010689257
-
Reproducibility Project: Cancer Biology. 2017. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
-
Mantis C, Kandela I, Aird F, Reproducibility Project: Cancer Biology. 2017. Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. eLife 6:e17584. doi: 10.7554/eLife.17584
-
Elife
, vol.6
-
-
Mantis, C.1
Kandela, I.2
Aird, F.3
-
12
-
-
84930652123
-
Time to do something about reproducibility
-
Morrison SJ. 2014. Time to do something about reproducibility. eLife 3:e03981. doi: 10.7554/eLife.03981
-
(2014)
Elife
, vol.3
-
-
Morrison, S.J.1
-
13
-
-
85010693234
-
Small molecules remain on target for c-Myc
-
Sun L, Gao P. 2017. Small molecules remain on target for c-Myc. eLife 6:e22915. doi: 10.7554/eLife.22915
-
(2017)
Elife
, vol.6
-
-
Sun, L.1
Gao, P.2
-
14
-
-
84860174226
-
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
-
Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, et al. 2012. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PNAS 109: 6662-6667. doi: 10.1073/pnas.1121623109
-
(2012)
PNAS
, vol.109
, pp. 6662-6667
-
-
Willingham, S.B.1
Volkmer, J.P.2
Gentles, A.J.3
Sahoo, D.4
Dalerba, P.5
Mitra, S.S.6
Wang, J.7
Contreras-Trujillo, H.8
Martin, R.9
Cohen, J.D.10
Lovelace, P.11
Scheeren, F.A.12
Chao, M.P.13
Weiskopf, K.14
Tang, C.15
Volkmer, A.K.16
Naik, T.J.17
Storm, T.A.18
Mosley, A.R.19
Edris, B.20
more..
|